Steward Partners Investment Advisory LLC Purchases 332 Shares of Doximity, Inc. (NASDAQ:DOCS)

Steward Partners Investment Advisory LLC lifted its position in Doximity, Inc. (NASDAQ:DOCS) by 17.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,269 shares of the company’s stock after acquiring an additional 332 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in Doximity were worth $121,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Plato Investment Management Ltd bought a new stake in Doximity during the 4th quarter valued at about $207,000. SBI Securities Co. Ltd. bought a new stake in Doximity during the 4th quarter valued at about $4,207,000. West Michigan Advisors LLC purchased a new position in Doximity during the 4th quarter valued at about $306,000. US Bancorp DE increased its position in Doximity by 7.8% during the 4th quarter. US Bancorp DE now owns 11,285 shares of the company’s stock valued at $603,000 after purchasing an additional 818 shares during the period. Finally, Fielder Capital Group LLC increased its position in Doximity by 4.5% during the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock valued at $293,000 after purchasing an additional 235 shares during the period. Institutional investors own 87.19% of the company’s stock.

Doximity Trading Up 4.2 %

Shares of NASDAQ DOCS opened at $63.33 on Monday. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The company has a 50 day simple moving average of $63.63 and a two-hundred day simple moving average of $52.72. The stock has a market cap of $11.82 billion, a price-to-earnings ratio of 63.33, a PEG ratio of 4.10 and a beta of 1.34.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 37.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. JPMorgan Chase & Co. raised their target price on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and raised their target price for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Piper Sandler raised shares of Doximity from a “neutral” rating to an “overweight” rating and raised their target price for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Stephens assumed coverage on shares of Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 target price on the stock. Finally, Raymond James reissued an “outperform” rating and set a $83.00 target price (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Doximity presently has a consensus rating of “Moderate Buy” and an average price target of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.